Sex differences in the efficacy and tolerability of antidepressants in the acute treatment of people with major depressive disorder: an individual-participant-data, dose-response, network meta-analysis

Depression is a common and serious mental health condition that affects millions of people worldwide, posing a significant challenge to individuals and society. It is characterized by persistent feelings of sadness, loss of interest or pleasure in activities, and a range of emotional and physical symptoms that can disrupt daily life, relationships, and overall well-being. It can severely impact daily life, relationships, and overall well-being, and it is associated with a high socioeconomic burden due to lost productivity and healthcare costs. Antidepressant medications are a key component of treatment, aiming to alleviate symptoms by modifying brain chemicals that regulate mood, such as serotonin and norepinephrine.

There are many types of antidepressants available, and while their effectiveness in treating depression is generally comparable, they can vary significantly in the side effects they cause. Choosing the right antidepressant is an important decision that involves weighing the benefits and risks of each option and considering the patient’s personal needs and preferences. A factor that may influence an antidepressant’s effectiveness and side effects is the patient’s sex (male or female), but current treatment guidelines do not provide clear, evidence-based recommendations tailored to these differences.

This research seeks to address this gap by analyzing individual data from patients who have used antidepressants in past studies. By examining detailed patient-level information, the study aims to investigate whether men and women differ in their responses to antidepressants in terms of efficacy, acceptability, and tolerability. The researchers hypothesize that women may respond better to antidepressants, require lower doses to achieve a response, and experience more side effects compared to men.

The findings from this study could enhance understanding of sex-based differences in depression treatment, providing the evidence needed to develop personalized treatment guidelines. This would help healthcare providers select the most suitable antidepressant for each patient, improving treatment outcomes while minimizing side effects.